The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia. - Qian Z; Bai YR; Zhou WJ; Zhang SN; Li JY; Sun Q; Wang YL; Wang DS; Liu HM; Yuan S; Jin ZP (Bioorganic chemistry, 2025)